TASHKENT, Uzbekistan, May 29. Uzbekistan will
introduce new financial incentives for domestic pharmaceutical
manufacturers starting June 1, Trend reports via country's legal information
portal.
The state-backed Trade Promotion Fund will reimburse
pharmaceutical companies for up to 50% of expenses related to
foreign consulting services and international certification
procedures. The support applies to compliance with EU GMP, U.S. FDA
GMP, and WHO prequalification standards, with compensation capped
at $50,000 per company.
Authorities are also expanding support for innovative medicines
and medical devices developed by local research institutes and
universities that have not previously been produced in
Uzbekistan.
Under the new rules, manufacturers will be eligible for
reimbursement covering up to 80% of registration expenses, clinical
trials, and bioequivalence studies, up to a maximum of $8,000. The
subsidy will be available after products enter industrial-scale
production and reach the market.
The reforms additionally ease participation rules for state
procurement tenders. Pharmaceutical and manufacturing companies
with limited outstanding tax liabilities will still be allowed to
compete for government contracts under certain conditions.
